Regenxbio Inc (RGNX)
Interest coverage
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -268,128 | -259,893 | -264,463 | -252,674 | -257,151 | 112,443 | 130,277 | 140,323 | 167,524 | -200,053 | -134,406 | -124,966 | -119,233 | -105,906 | -155,753 | -150,792 | -148,998 | -106,224 | -93,053 | -49,831 |
| Interest expense (ttm) | US$ in thousands | 6,862 | 9,809 | 14,139 | 19,879 | 23,254 | 25,444 | 26,199 | 25,705 | 26,277 | 20,548 | 13,839 | 7,473 | 771 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest coverage | -39.07 | -26.50 | -18.70 | -12.71 | -11.06 | 4.42 | 4.97 | 5.46 | 6.38 | -9.74 | -9.71 | -16.72 | -154.65 | — | — | — | — | — | — | — |
December 31, 2023 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-268,128K ÷ $6,862K
= -39.07
Regenxbio Inc's interest coverage ratio has fluctuated significantly over the past eight quarters, ranging from as low as -39.22 in Q4 2023 to a high of 5.32 in Q1 2022. A negative interest coverage ratio indicates that the company's operating income is insufficient to cover its interest expenses, suggesting a potential risk of liquidity problems or financial distress. The downward trend in interest coverage ratios from Q1 2022 to Q4 2023 indicates a deterioration in the company's ability to meet its interest obligations. It is crucial for Regenxbio Inc to closely monitor and address this downward trend to avoid potential financial difficulties in the future.
Peer comparison
Dec 31, 2023